晚期胃肠癌循环肿瘤DNA测序的临床效用:SCRUM-Japan GI-SCREEN与GOZILA研究
该研究比较了基于ctDNA测序(GOZILA研究,1687例晚期胃肠癌患者)与肿瘤组织测序(GI-SCREEN,5621例)在试验入组中的效用。ctDNA分型显著缩短筛选时间(11天 vs 33天,P<0.0001)并提高试验入组率(9.5% vs 4.1%,P<0.0001),且不损害治疗效果。研究还描述了约2000例晚期胃肠癌患者ctDNA图谱的克隆结构,强化了许多可靶向致癌驱动因素的相关性,并突出了多个新驱动因素作为临床开发候选。
要点
- ctDNA分型较组织分型显著缩短筛选时间(11天 vs 33天)。
- ctDNA分型显著提高试验入组率(9.5% vs 4.1%)。
- ctDNA分型不损害治疗效果,且可揭示可靶向驱动因素。
核心结论
- ctDNA分型可加速精准医学创新及其对个体患者的交付。
研究设计与样本
- 观察性ctDNA筛选研究GOZILA(UMIN000016343)纳入1687例晚期胃肠癌患者,与同中心网络的组织测序研究GI-SCREEN(5621例)进行比较。
主要发现
- ctDNA分型显著缩短筛选持续时间(11天 vs 33天,P<0.0001)。
- ctDNA分型显著提高试验入组率(9.5% vs 4.1%,P<0.0001)。
- ctDNA分型不损害治疗效果。
- 描述了约2000例晚期胃肠癌患者ctDNA图谱的克隆结构,强化了许多可靶向致癌驱动因素的相关性,并突出了多个新驱动因素作为临床开发候选。
临床怎么用
- ctDNA分型可用于晚期胃肠癌患者的试验筛选,缩短筛选时间并提高入组率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Comprehensive genomic profiling enables genomic biomarker detection in advanced solid tumors. Here, to evaluate the utility of circulating tumor DNA (ctDNA) genotyping, we compare trial enrollment using ctDNA sequencing in 1,687 patients with advanced gastrointestinal (GI) cancer in SCRUM-Japan GOZILA (no. UMIN000016343), an observational ctDNA-based screening study, to enrollment using tumor tissue sequencing in the same centers and network (GI-SCREEN, 5,621 patients). ctDNA genotyping significantly shortened the screening duration (11 versus 33 days, P < 0.0001) and improved the trial enrollment rate (9.5 versus 4.1%, P < 0.0001) without compromising treatment efficacy compared to tissue genotyping. We also describe the clonal architecture of ctDNA profiles in ~2,000 patients with advanced GI cancer, which reinforces the relevance of many targetable oncogenic drivers and highlights multiple new drivers as candidates for clinical development. ctDNA genotyping has the potential to accelerate innovation in precision medicine and its delivery to individual patients.
引用
- Nakamura Y, Taniguchi H, Ikeda M, et al. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies. Nat Med. 2020. PMID: 33020649. doi:10.1038/s41591-020-1063-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。